| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
|
Martínez-Cuadrón, David
|
|
2018
|
97 |
5 |
p. 763-772
|
artikel
|
| 2 |
Atypical chronic lymphocytic leukemia presenting with massive IgM paraprotein
|
Tachiki, Lisa
|
|
2018
|
97 |
5 |
p. 921-922
|
artikel
|
| 3 |
CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study
|
Wei, Guoqing
|
|
2018
|
97 |
5 |
p. 781-789
|
artikel
|
| 4 |
Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
|
Matsuda, Kana
|
|
2018
|
97 |
5 |
p. 877-883
|
artikel
|
| 5 |
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma
|
Nijland, Marcel
|
|
2018
|
97 |
5 |
p. 905-907
|
artikel
|
| 6 |
Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
|
Martínez-Cuadrón, David
|
|
2018
|
97 |
5 |
p. 923
|
artikel
|
| 7 |
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)
|
Di Blasi, Roberta
|
|
2018
|
97 |
5 |
p. 791-798
|
artikel
|
| 8 |
Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India
|
Chatterjee, Tridip
|
|
2018
|
97 |
5 |
p. 893-898
|
artikel
|
| 9 |
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment
|
Breccia, Massimo
|
|
2018
|
97 |
5 |
p. 745-754
|
artikel
|
| 10 |
Infections associated with ruxolitinib: study in the French Pharmacovigilance database
|
Sylvine, Pinel
|
|
2018
|
97 |
5 |
p. 913-914
|
artikel
|
| 11 |
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
|
Marhäll, Alissa
|
|
2018
|
97 |
5 |
p. 773-780
|
artikel
|
| 12 |
Leukemia-propagating cells demonstrate distinctive gene expression profiles compared with other cell fractions from patients with de novo Philadelphia chromosome-positive ALL
|
Zhao, Hong-Yan
|
|
2018
|
97 |
5 |
p. 799-811
|
artikel
|
| 13 |
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review
|
Cencini, Emanuele
|
|
2018
|
97 |
5 |
p. 821-829
|
artikel
|
| 14 |
Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications
|
Stoma, Igor
|
|
2018
|
97 |
5 |
p. 885-891
|
artikel
|
| 15 |
PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft
|
Chen, Ping
|
|
2018
|
97 |
5 |
p. 865-875
|
artikel
|
| 16 |
Polyneuropathy and myopathy in beta-thalassemia major patients
|
Nemtsas, P.
|
|
2018
|
97 |
5 |
p. 899-904
|
artikel
|
| 17 |
Prognostic risk models for transplant decision-making in myelofibrosis
|
Hernández-Boluda, Juan-Carlos
|
|
2018
|
97 |
5 |
p. 813-820
|
artikel
|
| 18 |
Relapse of acute promyelocytic leukemia in the external auditory canal confirmed by PML/RARA dual-fusion and RARA break-apart fluorescence in situ hybridization
|
Minoda, Saki
|
|
2018
|
97 |
5 |
p. 909-911
|
artikel
|
| 19 |
Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma
|
Chen, Ying
|
|
2018
|
97 |
5 |
p. 851-863
|
artikel
|
| 20 |
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma
|
Fouquet, Guillemette
|
|
2018
|
97 |
5 |
p. 831-837
|
artikel
|
| 21 |
Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia
|
Suzuki, Yutaro
|
|
2018
|
97 |
5 |
p. 917-919
|
artikel
|
| 22 |
Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma
|
Adams, Hugo J.A.
|
|
2018
|
97 |
5 |
p. 915-916
|
artikel
|
| 23 |
Sleep-disordered breathing in patients with sickle cell disease
|
Raghunathan, Vikram M.
|
|
2017
|
97 |
5 |
p. 755-762
|
artikel
|
| 24 |
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma
|
Breitkreutz, Iris
|
|
2018
|
97 |
5 |
p. 839-849
|
artikel
|
Tijdschrift beschrijving